Boehringer Ingelheim GmbH didn’t disclose a data analysis to U.S. regulators that indicated the blood-thinner Pradaxa may have caused more fatal bleeding after it was cleared for sale than the drug did in a study used to win approval, unsealed court filings show.
Medtronic Inc. said it will make the data on its embattled bone-growth product Infuse available to the public and pay for two independent analyses of the information in a move the company says may set a new industry standard.
General Mills Inc. ’s Cheerios are among the foods that should be held to the same scientific standards as pharmaceuticals when promoted as having health benefits, a report ordered by U.S. regulators said today.
An experimental drug from Merck & Co. raised levels of good cholesterol, slashed bad cholesterol and may have helped patients avert heart complications, without the safety risks that prompted Pfizer Inc. to abandon a similar product four years ago.
U.S. patients of doctors who went to medical school outside the country and weren’t American citizens had a 9 percent lower death rate on average than those whose doctors trained at home, a study showed.